BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1860265)

  • 21. Predictive factors for ciclosporin-associated nephrotoxicity in children with minimal change nephrotic syndrome.
    Kim JH; Park SJ; Yoon SJ; Lim BJ; Jeong HJ; Lee JS; Kim PK; Shin JI
    J Clin Pathol; 2011 Jun; 64(6):516-9. PubMed ID: 21441261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single-center experience with cyclosporine for treatment of idiopathic minimal change nephrotic syndrome in children.
    Sabry A; El-Husseini A; El-Dahshan K; Sobh M
    Iran J Kidney Dis; 2009 Jul; 3(3):127-35. PubMed ID: 19617660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclosporin A in nephrotic syndrome of childhood--a 14 month experience.
    Capodicasa G; De Santo NG; Nuzzi F; Giordano C
    Int J Pediatr Nephrol; 1986; 7(2):69-72. PubMed ID: 3522457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-centre experience with cyclosporin in 106 children with idiopathic focal segmental glomerulosclerosis.
    Mahmoud I; Basuni F; Sabry A; El-Husseini A; Hassan N; Ahmad NS; Elbaz M; Moustafa F; Sobh M
    Nephrol Dial Transplant; 2005 Apr; 20(4):735-42. PubMed ID: 15772265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
    Ehrich JH; Geerlings C; Zivicnjak M; Franke D; Geerlings H; Gellermann J
    Nephrol Dial Transplant; 2007 Aug; 22(8):2183-93. PubMed ID: 17504846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Henoch-Schönlein purpura nephritis with nephrotic-range proteinuria: histological regression possibly associated with cyclosporin A and steroid treatment.
    Shin JI; Park JM; Shin YH; Kim JH; Lee JS; Jeong HJ
    Scand J Rheumatol; 2005; 34(5):392-5. PubMed ID: 16234188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclosporine experience in nephrotic syndrome.
    Phadke K; Ballal S; Maiya V
    Indian Pediatr; 1998 Feb; 35(2):111-6. PubMed ID: 9707852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of high-age minimal change nephrotic syndrome relapse after 18-year remission and effective treatment with steroid and cyclosporin combined therapy].
    Yoshimoto K; Wada T; Iwata Y; Sakai N; Shimizu M; Furuichi K; Yokoyama H; Kobayashi K
    Nihon Jinzo Gakkai Shi; 2000 Oct; 42(8):640-3. PubMed ID: 11195400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclosporine in steroid dependent and resistant childhood nephrotic syndrome.
    Iyengar A; Karthik S; Kumar A; Biswas S; Phadke K
    Indian Pediatr; 2006 Jan; 43(1):14-9. PubMed ID: 16465001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cyclosporin therapy in minimal change nephritis].
    Balcke P; Derfler K; Stockenhuber F; Kopsa H; Sunder-Plassmann G
    Wien Klin Wochenschr; 1987 Apr; 99(7):242-5. PubMed ID: 3590804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective conversion from azathioprine to cyclosporin for steroid-resistant rejection in renal transplants: an alternative therapy.
    Crowson MC; Berisa F; McGonigle RJ; Adu D; Michael J; Barnes AD
    Nephrol Dial Transplant; 1989; 4(2):129-32. PubMed ID: 2496354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kidney biopsies in control or cyclosporin A-treated psoriatic patients. International Kidney Biopsy Registry of Cyclosporin A (Sandimmun) in Autoimmune Diseases.
    Br J Dermatol; 1990 Jun; 122 Suppl 36():95-100. PubMed ID: 2369573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison between pre- and posttreatment renal biopsies in children receiving ciclosporine for idiopathic nephrosis.
    Habib R; Niaudet P
    Clin Nephrol; 1994 Sep; 42(3):141-6. PubMed ID: 7994931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacokinetic of cyclosporin A].
    Bourdat-Michel G; Dechelette E; Serre-Debeauvais F; Bost M; Beaudoing A
    Pediatrie; 1990; 45(9):571-5. PubMed ID: 2175417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of cyclosporin A on glomerular filtration rate in children with minimal change nephrotic syndrome.
    Hulton SA; Jadresic L; Shah V; Trompeter RS; Dillon MJ; Barratt TM
    Pediatr Nephrol; 1994 Aug; 8(4):404-7. PubMed ID: 7947024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [T-cell lymphoma under immunosuppressive treatment in minimal change glomerulopathy with nephrotic syndrome].
    Späth M; Schollmeyer P
    Dtsch Med Wochenschr; 1995 Aug; 120(34-35):1161-4. PubMed ID: 7656849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclosporin A treatment of severe steroid resistant nephrotic syndrome in adults.
    Nyrop M; Olgaard K
    J Intern Med; 1990 Jan; 227(1):65-8. PubMed ID: 2299300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term benefits and risks of cyclosporin A (sandimmun)--an analysis at 10 years.
    Thiel G; Bock A; Spöndlin M; Brunner FP; Mihatsch M; Rufli T; Landmann J
    Transplant Proc; 1994 Oct; 26(5):2493-8. PubMed ID: 7940765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The kidney in cyclosporin A-treated diabetic patients: a long-term clinicopathological study.
    Assan R; Timsit J; Feutren G; Bougnères P; Czernichow P; Hannedouche T; Boitard C; Noel LH; Mihatsch MJ; Bach JF
    Clin Nephrol; 1994 Jan; 41(1):41-9. PubMed ID: 8137568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of idiopathic nephrotic syndrome with cyclosporine A.
    Meyrier A
    J Nephrol; 1997; 10(1):14-24. PubMed ID: 9241620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.